Table 1.
Clinicopathological characteristics | Liver cancer, overall survival (n = 364) | Liver hepatocellular carcinoma, overall survival (n = 7462) | ||||
---|---|---|---|---|---|---|
N | Hazard ratio | p value | N | Hazard ratio | p value | |
AJCC T | ||||||
1 | 181 | 2.33 (1.07-5.05) | 0.028 | |||
2 | 94 | 2.96 (1.26-6.95) | <0.01 | |||
3 | 80 | 1.71 (0.91-3.22) | 0.092 | |||
Vascular invasion | ||||||
None | 205 | 2.05 (1.19-3.53) | <0.01 | |||
Macro | 93 | 2.79 (0.84-9.33) | 0.082 | |||
RACE | ||||||
Asian | 158 | 3.06 (1.69-5.54) | <0.01 | |||
White | 184 | 2.51 (1.37-4.6) | <0.01 | |||
Alcohol consumption | ||||||
Yes | 117 | 2.42 (1.27-4.6) | <0.01 | |||
None | 205 | 2.19 (1.35-3.55) | <0.01 | |||
Hepatitis virus | ||||||
Yes | 153 | 2.22 (1.15-4.29) | 0.015 | |||
None | 169 | 3.19 (1.78-5.7) | <0.01 | |||
CD8+T cells | ||||||
Enriched | 3601 | 3.05 (1.53-6.09) | <0.01 | |||
Decreased | 3416 | 2.48 (1.63-3.78) | <0.01 | |||
Tregs | ||||||
Enriched | 3434 | 1.75 (1.15-2.66) | <0.01 | |||
Decreased | 3583 | 1.53 (0.70-3.34) | 0.29 | |||
B cell | ||||||
Enriched | 3763 | 3.50 (1.52-8.06) | <0.01 | |||
Decreased | 3254 | 2.54 (1.69-3.80) | <0.01 | |||
Macrophages | ||||||
Enriched | 3983 | 2.65 (1.66-4.24) | <0.01 | |||
Decreased | 3034 | 2.96 (1.63-5.35) | <0.01 |